SMi are delighted to have interviewed our speaker Naj Sharif, Executive Director and Head, Global Alliances & External Research, Santen regarding his thoughts and experiences w
With the event now Just 1 week away, I wanted to remind you that there is still time to secure your place at Europe's Leading Ophthalmic Conference; SMi's Ophthalmic Drugs, taking place on November
Presenting issues and real-life examples within the ophthalmology industry including ocular diseases, drug delivery, pre-clinical and clinical trials, computer technologies, therapies for diabetic
In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho